In particular, Meis1 was upregulated in breast, neuroblastoma, gynecologic, skin, sarcoma, and thymoma cancers, which may be associated with cancer cell survival, proliferation, and tumorigenesis. This evidence concerns the gene MEIS1 and neuroblastoma.